Kaplan-Meier curve analysis of all four outcome indicators suggested that higher PDIA3 expression in CESC was associated with poorer survival outcomes, indicating the important role of PDIA3 in the prognosis of KIRP, KICH, and CESC patients and its potential as a prognostic biomarker. This evidence concerns the gene PDIA3 and cervical squamous cell carcinoma.